TY - JOUR
T1 - Calciprotein Particles Balancing Mineral Homeostasis and Vascular Pathology
T2 - Balancing Mineral Homeostasis and Vascular Pathology
AU - Kutikhin, Anton G
AU - Feenstra, Lian
AU - Kostyunin, Alexander E
AU - Yuzhalin, Arseniy E
AU - Hillebrands, Jan-Luuk
AU - Krenning, Guido
PY - 2021/5/5
Y1 - 2021/5/5
N2 - Hypercalcemia and hyperphosphatemia associate with an elevated risk of cardiovascular events, yet the pathophysiological basis of this association is unclear. Disturbed mineral homeostasis and the associated hypercalcemia and hyperphosphatemia may result in the formation of circulating calciprotein particles (CPPs) that aggregate the excessive calcium and phosphate ions. If not counteracted, the initially formed harmless amorphous spherical complexes (primary CPPs) may mature into damaging crystalline complexes (secondary CPPs). Secondary CPPs are internalized by vascular cells, causing a massive influx of calcium ions into the cytosol, leading to a proinflammatory response, cellular dysfunction, and cell death. Although the pathophysiological effects induced by CPPs in vascular cells receive increasing attention, a complete picture of how these particles contribute to the development of atherosclerosis and vascular calcification remains elusive. We here discuss existing knowledge on CPP formation and function in atherosclerosis and vascular calcification, techniques for investigating CPPs, and models currently applied to assess CPP-induced cardiovascular pathogenesis. Lastly, we evaluate the potential diagnostic value of serum CPP measurements and the therapeutic potential of anti-CPP therapies currently under development.
AB - Hypercalcemia and hyperphosphatemia associate with an elevated risk of cardiovascular events, yet the pathophysiological basis of this association is unclear. Disturbed mineral homeostasis and the associated hypercalcemia and hyperphosphatemia may result in the formation of circulating calciprotein particles (CPPs) that aggregate the excessive calcium and phosphate ions. If not counteracted, the initially formed harmless amorphous spherical complexes (primary CPPs) may mature into damaging crystalline complexes (secondary CPPs). Secondary CPPs are internalized by vascular cells, causing a massive influx of calcium ions into the cytosol, leading to a proinflammatory response, cellular dysfunction, and cell death. Although the pathophysiological effects induced by CPPs in vascular cells receive increasing attention, a complete picture of how these particles contribute to the development of atherosclerosis and vascular calcification remains elusive. We here discuss existing knowledge on CPP formation and function in atherosclerosis and vascular calcification, techniques for investigating CPPs, and models currently applied to assess CPP-induced cardiovascular pathogenesis. Lastly, we evaluate the potential diagnostic value of serum CPP measurements and the therapeutic potential of anti-CPP therapies currently under development.
KW - atherosclerosis
KW - calcium
KW - homeostasis
KW - hypercalcemia
KW - hyperphosphatemia
KW - vascular calcification
KW - SMOOTH-MUSCLE-CELLS
KW - PERIVASCULAR ADIPOSE-TISSUE
KW - SERUM CALCIFICATION PROPENSITY
KW - BONE MORPHOGENETIC PROTEIN-2
KW - CORONARY-ARTERY CALCIFICATION
KW - CHRONIC KIDNEY-DISEASE
KW - MATRIX GLA-PROTEIN
KW - ALL-CAUSE MORTALITY
KW - HUMAN-BODY FLUIDS
KW - FETUIN-A
U2 - 10.1161/ATVBAHA.120.315697
DO - 10.1161/ATVBAHA.120.315697
M3 - Review article
C2 - 33691479
SN - 1079-5642
VL - 41
SP - 1607
EP - 1624
JO - Arteriosclerosis, thrombosis, and vascular biology
JF - Arteriosclerosis, thrombosis, and vascular biology
IS - 5
ER -